Survodutide

For Research Use Only

Survodutide is a dual agonist targeting the GLP-1 and Glucagon receptors. Its main function is to treat obesity and related metabolic disorders by increasing energy expenditure and reducing appetite. It is currently in clinical trials.

$343.00